Marshall Wace’s Celularity CELU Stock Holding History

Marshall Wace’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,253	Closed	-$247K	–	3379
2022 Q2	$247K	Buy	+7,253	New	+$589K	﹤0.01%	3091
2021 Q4	–	Sell	-1,229	Closed	-$87K	–	3896
2021 Q3	$87K	Buy	+1,229	New	+$99.2K	﹤0.01%	2906

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LDFO

Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace's CELU Position: Q3 2022 in Review

Marshall Wace sold out of Celularity (CELU) in Q3 2022, closing a stake of 7,253 shares — an estimated $247K sold.

Marshall Wace first reported a position in CELU in Q3 2021 and held it in 2 quarters. The position peaked at $247K in Q2 2022. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

Marshall Wace reported no remaining Celularity position as of Q3 2022 after selling out during the quarter.
Marshall Wace sold 7,253 Celularity shares in Q3 2022, an estimated $247K.
Marshall Wace first reported a position in Celularity in Q3 2021 and held it in 2 quarters.
Marshall Wace's Celularity position peaked at $247K in Q2 2022.
72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.